These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28757277)

  • 1. Haemodiafiltration with ultrafiltrate regeneration in the removal of free light chains in multiple myeloma and acute kidney injury.
    Li Cavoli G; Passanante S; Schillaci O; Servillo F; Zagarrigo C; Li Cavoli TV; Palmeri M; Palma B; Rotolo U
    Nefrologia (Engl Ed); 2018; 38(3):337-338. PubMed ID: 28757277
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients.
    Pendón-Ruiz de Mier MV; Ojeda R; Álvarez-Lara MA; Navas A; Alonso C; Caballero-Villarraso J; Aljama P; Álvarez MA; Soriano S; Rodríguez M; Martín-Malo A
    BMC Nephrol; 2020 Jun; 21(1):227. PubMed ID: 32539688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series.
    Menè P; Giammarioli E; Fofi C; Antolino G; Verde G; Tafuri A; Punzo G; Festuccia F
    Kidney Blood Press Res; 2018; 43(4):1263-1272. PubMed ID: 30078004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of haemodiafiltration with ultrafiltrate regeneration in the reduction of light chains in multiple myeloma with renal failure.
    Pendón-Ruiz de Mier MV; Alvarez-Lara MA; Ojeda-López R; Martín-Malo A; Carracedo J; Caballero-Villarraso J; Alonso C; Aljama P
    Nefrologia; 2013 Nov; 33(6):788-96. PubMed ID: 24241366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
    Rousseau-Gagnon M; Agharazii M; De Serres SA; Desmeules S
    PLoS One; 2015; 10(10):e0140463. PubMed ID: 26466100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of SUPRA HFR in the treatment of acute renal damage during multiple myeloma].
    Daidola G; Guarena C; Brustia M; Leonardi G; Vigotti FN; Marciello A; Bianco S; Chiarinotti D; Saltarelli M; Besso L; Biancone L
    G Ital Nefrol; 2018 Dec; 35(6):. PubMed ID: 30550040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel option for reducing free light chains in myeloma kidney: supra-hemodiafiltration with endogenous reinfusion (HFR).
    Pasquali S; Iannuzzella F; Corradini M; Mattei S; Bovino A; Stefani A; Palladino G; Caiazzo M
    J Nephrol; 2015 Apr; 28(2):251-4. PubMed ID: 25149172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion.
    Murgia S; Quattrocchio G; Forneris G; Pozzato M; Fenoglio R; Ferro M; De Simone E; Del Vecchio G; Di Benedetto C; Roccatello D
    J Nephrol; 2022 May; 35(4):1243-1249. PubMed ID: 34982413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
    Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable kidney recovery by extracorporeal light chain removal and anti-myeloma treatments in patients with newly diagnosed multiple myeloma and acute renal failure.
    Silvestrini G; Tatangelo P; Scaramucci L; Sfara G; Bondanini F; Niscola P; de Fabritiis P; Palumbo R
    Saudi J Kidney Dis Transpl; 2020; 31(6):1445-1447. PubMed ID: 33565464
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible acute kidney injury (AKI) by active removal of serum light chains in an HIV positive patient with myeloma kidney.
    Sowole L; Burns A; Kaur B; Davenport A
    Clin Nephrol; 2011 Nov; 76(5):417-20. PubMed ID: 22000564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal depuration technique as treatment of acute kidney injury related to multiple myeloma.
    Gil Carballeira I; Fort Ros J; Ramos Sánchez R
    Ther Apher Dial; 2013 Jun; 17(3):351-2. PubMed ID: 23735155
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloma light chain cast nephropathy, a review.
    Sathick IJ; Drosou ME; Leung N
    J Nephrol; 2019 Apr; 32(2):189-198. PubMed ID: 29730782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of haemodiafiltration with ultrafiltrate regeneration in renal failure due to multiple myeloma.
    Pendón-Ruiz de Mier MV; Ojeda-López R; Alvarez de Lara-Sánchez MA; Martín-Malo A; Aljama-García P
    Nefrologia; 2013; 33(3):426-8. PubMed ID: 23712232
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal improvement in myeloma with plasma exchange.
    Hutchison C; Bridoux F; Fermand JP
    N Engl J Med; 2011 Sep; 365(11):1061; author reply 1062. PubMed ID: 21916654
    [No Abstract]   [Full Text] [Related]  

  • 16. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
    Cockwell P; Cook M
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):324-32. PubMed ID: 22920643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy.
    Mehta S; Shtaynberg N; Goldman M; Asti D; Kiroycheva M; Pepe J
    Hematology; 2012 Jul; 17(4):229-31. PubMed ID: 22889516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal improvement in myeloma with bortezomib plus plasma exchange.
    Burnette BL; Leung N; Rajkumar SV
    N Engl J Med; 2011 Jun; 364(24):2365-6. PubMed ID: 21675906
    [No Abstract]   [Full Text] [Related]  

  • 19. The Case | A 53-year-old woman with acute kidney injury and multiple myeloma.
    Kudose S; Suarez-Fuentes C; D'Agati VD; Markowitz GS
    Kidney Int; 2019 Oct; 96(4):1045-1046. PubMed ID: 31543145
    [No Abstract]   [Full Text] [Related]  

  • 20. Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities.
    Davenport A; Merlini G
    Nephrol Dial Transplant; 2012 Oct; 27(10):3713-8. PubMed ID: 23114897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.